此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Hospital-acquired Pneumonia in Intensive Care Unit (PNEUMOCARE)

2020年5月8日 更新者:Nantes University Hospital

Hospital Acquired and Ventilator Associated Pneumonia : Impact of the New French Guidelines on Patients Care and Outcomes.

hospital-acquired pneumonia are a common disease in intensive care unit. The prevention, the diagnosis and the treatment of hospital acquired pneumonia are a frequent challenge. Nevertheless it seems that there are great differences in standard of care between hospitals. The investigators hypothesized that medical education and implementation of evidence-base guidelines can reduce the duration of mechanical ventilation in patients presenting of hospital acquired pneumonia

研究概览

详细说明

The before period (phase 1) will consist of all consecutive patients admitted to the participating ICUs before the national guidelines publication concerning healthcare associated pneumonia.

The second period (phase 2) will consist of all consecutive patients admitted to the participating ICUs after the publication of the national guidelines publication concerning healthcare associated pneumonia.

Afterward, an interphase will occur during which all physicians, residents, physiotherapists and nurses will receive a formal training for the processes and procedures related to the new guidelines published in september 2017.

In the intervention group, on top of the standard training, the centers receive an analysis of the evolution of the practices of their center and the future of their patients between phases 1 and 2, as well as these same values for the data set. The centers are then called to conduct a meeting to determine their priority improvement points based on this audit.

The third and final period (phase 3) will consist of all consecutive patients admitted to the participating ICUs after the formal training.

研究类型

观察性的

注册 (实际的)

1850

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

      • Nantes、法国、44093
        • CHU de Nantes

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

取样方法

非概率样本

研究人群

adult patients hospitalized in intensive care units with a hospital stay greater than 72 hours and a GIs-II greater than or equal to 15.

描述

Inclusion Criteria:

  • Age > 18 years ; IGS-II score > 15 ; Hospital stay >= 3 days

Exclusion Criteria:

  • Community-acquired pneumonia, pregnant women, refusal to participate

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 观测模型:仅案例
  • 时间观点:预期

队列和干预

团体/队列
干预/治疗
The before period
The before period (control phase) will consist of all consecutive patients admitted to the participating ICUs before the national guidelines publication concerning hospital-acquired pneumonia.
Passing recommendations on using the guidelines in the intensive care units
The second period

Intensive care units are randomized in two groups:

Standard training: The centers will receive the text of the recommendation electronically. The principal investigator of each center will then train doctors, interns, nurses and physiotherapists to the use of these recommendations (team leader). A computer presentation common to all the centers will be used and a communication strategy vis-à-vis the other caregivers of the investigative services will be put in place. All doctors, interns and nurses must have attended this theoretical training during the awareness phase.

Passing recommendations on using the guidelines in the intensive care units
Targeted experience feedback": On top of the standard training, the centers receive an analysis of the evolution of the practices of their center and the future of their patients between phases 1 and 2, as well as these same values for the data set. The centers are then called to conduct a meeting to determine their priority improvement points based on this audi
The third and final period
The third and final period will consist of all consecutive patients admitted to the participating ICUs after the formal training.
Passing recommendations on using the guidelines in the intensive care units

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Unit length of stay
大体时间:28 days
Duration of ICU hospitalization Safety Issue: NA
28 days

次要结果测量

结果测量
措施说明
大体时间
Intensive Care Unit free-days at day 28
大体时间:28 days
The number of days from day 1 to day 28 on which a patient is alive outside of intensive care unit Safety Issue
28 days
Hospital-acquired pneumonia
大体时间:28 days
definition based on the appearance of a new infiltrate or changes in an existing infiltrate on chest X-ray associated with any two of the following clinical signs: body temperature >38°C, leucocytosis >12,000/ml or leukopenia <4000/ml, and purulent pulmonary secretions that were associated with a positive quantitative or semi-quantitative bacteriological culture of a respiratory tract sample.
28 days
Composite measure of compliance to guidelines
大体时间:28 days
defined as the total number of performed eligible measures divided by the total number of measures for which each patient was eligible
28 days
Empirical treatment failure
大体时间:28 days
Defined as one or more pathogen involved in the pneumonia is not susceptible to the antibiotics used empirically
28 days

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Antoine Roquilly, PH、CHU de Nantes

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2017年9月15日

初级完成 (实际的)

2018年10月15日

研究完成 (实际的)

2018年12月15日

研究注册日期

首次提交

2017年11月16日

首先提交符合 QC 标准的

2017年11月16日

首次发布 (实际的)

2017年11月21日

研究记录更新

最后更新发布 (实际的)

2020年5月12日

上次提交的符合 QC 标准的更新

2020年5月8日

最后验证

2017年11月1日

更多信息

与本研究相关的术语

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

在美国制造并从美国出口的产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅